Glow Lifetech Corp. (GLWLF)
USD 0.04
(-10.06%)
USD 0.04
(-10.06%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.64 Million CAD | 25.88% |
| 2022 | -1.67 Million USD | 81.27% |
| 2021 | -8.94 Million USD | -7325.21% |
| 2020 | -120.47 Thousand USD | -178.3% |
| 2019 | -43.28 Thousand USD | 68.46% |
| 2018 | -137.26 Thousand USD | 61.66% |
| 2017 | -358.03 Thousand USD | -205.89% |
| 2016 | 338.1 Thousand USD | 132.74% |
| 2015 | -1.03 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -193.27 Thousand USD | 47.38% |
| 2024 Q2 | -189.09 Thousand USD | 1.16% |
| 2023 FY | -1.24 Million USD | 25.88% |
| 2023 Q4 | -375.39 Thousand USD | -39.37% |
| 2023 Q3 | -269.35 Thousand USD | 9.95% |
| 2023 Q2 | -299.1 Thousand USD | -16.56% |
| 2023 Q1 | -256.61 Thousand USD | 58.9% |
| 2022 Q4 | -624.43 Thousand USD | -179.83% |
| 2022 FY | -1.67 Million USD | 81.27% |
| 2022 Q3 | -223.14 Thousand USD | 44.32% |
| 2022 Q2 | -400.74 Thousand CAD | 16.35% |
| 2022 Q1 | -479.06 Thousand CAD | 29.64% |
| 2021 Q1 | -8.26 Million CAD | -83064.27% |
| 2021 Q4 | -680.87 Thousand CAD | -90.06% |
| 2021 FY | -8.94 Million USD | -7325.21% |
| 2021 Q3 | -358.24 Thousand CAD | 62.09% |
| 2021 Q2 | -944.93 Thousand CAD | 88.56% |
| 2020 Q4 | 9958.00 CAD | 101.44% |
| 2020 FY | -120.47 Thousand USD | -178.3% |
| 2020 Q3 | -691.52 Thousand CAD | -1679.42% |
| 2020 Q2 | -38.86 Thousand CAD | 1.13% |
| 2020 Q1 | -39.3 Thousand CAD | -70.88% |
| 2019 Q1 | -21.58 Thousand CAD | 0.0% |
| 2019 FY | -43.28 Thousand USD | 68.46% |
| 2019 Q4 | -23 Thousand CAD | 34.99% |
| 2019 Q3 | -35.38 Thousand CAD | -248.46% |
| 2019 Q2 | 23.83 Thousand CAD | 210.41% |
| 2018 FY | -137.26 Thousand USD | 61.66% |
| 2017 FY | -358.03 Thousand USD | -205.89% |
| 2016 FY | 338.1 Thousand USD | 132.74% |
| 2015 FY | -1.03 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 97.805% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 74.976% |
| SQZ Biotechnologies Company | -79.46 Million USD | 97.929% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 103.106% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 102.527% |
| Mesoblast Limited | -87.95 Million USD | 98.129% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 9.608% |
| Genus plc | 7.9 Million USD | 120.831% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 84.891% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 55.647% |
| Marizyme, Inc. | -65.34 Million USD | 97.482% |
| ContraFect Corporation | -65.15 Million USD | 97.474% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 81.393% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 66.32% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 4.738% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 43.106% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 79.582% |
| MultiCell Technologies, Inc. | -380.07 USD | -432876.031% |
| Accustem Sciences Inc. | -3.74 Million USD | 56.075% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 96.817% |
| EV Biologics, Inc. | -1.26 Million USD | -29.869% |
| Q BioMed Inc. | -2.05 Million USD | 19.808% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 55.917% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -160.214% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 30.882% |
| Biomind Labs Inc. | -1.21 Million USD | -35.517% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | -10.54 Million USD | 84.399% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 79.178% |
| Skye Bioscience, Inc. | -37.64 Million USD | 95.629% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 24.159% |
| THC Farmaceuticals, Inc. | -14.97 Thousand USD | -10888.328% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 76.433% |
| IMV Inc. | -36.48 Million USD | 95.49% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 89.632% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 71.712% |
| GB Sciences, Inc. | -1.36 Million USD | -20.852% |
| Alpha Cognition Inc. | -13.77 Million USD | 88.052% |
| HST Global, Inc. | -146.21 Thousand USD | -1025.513% |
| CSL Limited | 2.64 Billion USD | 100.062% |
| Halberd Corporation | -79.67 Thousand USD | -1965.38% |
| Enzolytics Inc. | -2.17 Million USD | 24.403% |
| Resverlogix Corp. | -3.61 Million USD | 54.415% |
| Affymax, Inc. | -14.42 Million USD | 88.591% |
| SYBLEU INC | -180.3 Thousand USD | -812.687% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 48.111% |
| argenx SE | -295.05 Million USD | 99.442% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 97.371% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 1779.196% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 58.58% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 45.62% |
| AVAX Technologies, Inc. | -6.41 Million USD | 74.342% |
| Zenith Capital Corp. | -10.59 Million USD | 84.469% |
| Genscript Biotech Corporation | -95.47 Million USD | 98.276% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | -6980.337% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 60.308% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | -2622.693% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 97.245% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 46.946% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -1.05 Million USD | -55.826% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 15.577% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 56.91% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 17.929% |
| BioStem Technologies, Inc. | -8.48 Million USD | 80.601% |
| ONE Bio Corp. | 8.67 Million USD | 118.966% |
| Reve Technologies, Inc. | -441.36 Thousand USD | -272.843% |
| Burzynski Research Institute, Inc. | -1.33 Million USD | -23.227% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 6.221% |
| Agentix Corp. | -1.37 Million USD | -19.75% |
| LadRx Corporation | 400.44 Thousand USD | 510.948% |
| Cell Source, Inc. | -5.32 Million USD | 69.074% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | -296.076% |
| Regen BioPharma, Inc. | 1.02 Million USD | 260.782% |
| Regen BioPharma, Inc. | 1.02 Million USD | 260.782% |
| NovAccess Global Inc. | -4.76 Million USD | 65.495% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 123.765% |
| Itoco Inc. | -1.86 Million USD | 11.952% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 62.958% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 1.401% |
| Kadimastem Ltd | -3.3 Million USD | 50.245% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | -501.902% |
| CytoDyn Inc. | -49.84 Million USD | 96.698% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | -1982.183% |
| Mobile Lads Corp. | -2.26 Million USD | 27.291% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | -621.358% |
| Qrons Inc. | -789.34 Thousand USD | -108.478% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | -74.781% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -2.08 Million USD | 21.175% |
| Rebus Holdings, Inc. | -1.02 Million USD | -61.335% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | -2.038% |
| International Stem Cell Corporation | -131 Thousand USD | -1156.192% |
| Bioxytran, Inc. | -4.28 Million USD | 61.551% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | -2932.157% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 34.962% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 96.577% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 22.156% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | -110.736% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 48.055% |
| Neutra Corp. | -233.46 Thousand USD | -604.865% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 91.89% |
| PureTech Health plc | -65.69 Million USD | 97.495% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 92.262% |
| IXICO plc | -1.17 Million USD | -39.695% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 83.423% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 97.119% |
| CSL Limited | 2.64 Billion USD | 100.062% |
| Cellectis S.A. | -103.17 Million USD | 98.405% |